1. Robbins MS. Diagnosis and management of headache: a review. JAMA.2021;325(18):1874-1885.
2. Saylor D, Steiner TJ. The global burden of headache. Semin Neurol. 2018;38(2):182-190.
3. Caponnetto V, Deodato M, Robotti M, et al. Comorbidities of primaryheadache disorders: a literature review with meta-analysis. J HeadachePain. 2021;22(1):71.
4. Giamberardino MA, Affaitati G, Costantini R, Guglielmetti M, MartellettiP. Acute headache management in emergency department. A narrativereview. Intern Emerg Med. 2020;15(1):109-117.
5. Kubik SU, Martin PR. The headache triggers sensitivity and avoidancequestionnaire: establishing the psychometric properties of thequestionnaire. Headache. 2017;57(2):236-254.
6. Chung PW, Cho SJ, Kim BK, et al. Development and validation of thecluster headache screening questionnaire. J Clin Neurol. 2019;15(1):90-96.
7. Steiner TJ, Gururaj G, Andrée C, et al. Diagnosis, prevalence estimationand burden measurement in population surveys of headache: presentingthe HARDSHIP questionnaire. J Headache Pain. 2014;15(1):3.
8. Burish MJ, Pearson SM, Shapiro RE, Zhang W, Schor LI. Cluster headacheis one of the most intensely painful human conditions: results from theInternational Cluster Headache Questionnaire. Headache. 2021;61(1):117-124.
9. Walling A. Frequent headaches: evaluation and management. Am FamPhysician. 2020;101(7):419-428.
10. Ailani J, Burch RC, Robbins MS; Board of Directors of the AmericanHeadache Society. The American Headache Society Consensus Statement:update on integrating new migraine treatments into clinical practice.Headache. 2021;61(7):1021-1039.
11. Bottiroli S, Renzi A, Ballante E, et al. Personality in chronic headache: asystematic review with meta-analysis. Pain Res Manag. 2023;2023:6685372.
12. Sun-Edelstein C, Rapoport AM, Rattanawong W, Srikiatkhachorn A. Theevolution of medication overuse headache: history, pathophysiology andclinical update. CNS Drugs. 2021;35(5):545-565.
13. Westergaard ML, Lau CJ, Allesøe K, Gjendal ST, Jensen RH. Monitoringchronic headache and medication-overuse headache prevalence inDenmark. Cephalalgia. 2020;40(1):6-18.
14. Kaur K, Hernandez V, Al Hajaj SW, et al. The efficacy of herbal supplementsand nutraceuticals for prevention of migraine: can they help? Cureus.2021;13(5):e14868.
15. Katsuki M, Kawamura S, Kashiwagi K, Koh A. Medication overuseheadache successfully treated by Japanese herbal kampo medicine,yokukansan. Cureus. 2021;13(9):e18326.
16. Rossi MF, Tumminello A, Marconi M, et al. Sex and gender differences inmigraines: a narrative review. Neurol Sci. 2022;43(9):5729-5734.
17. Fuensalida-Novo S, Parás-Bravo P, Jiménez-Antona C, et al. Genderdifferences in clinical and psychological variables associated with theburden of headache in tension-type headache. Women Health. 2020;60(6):652-663.
18. Al-Hassany L, Haas J, Piccininni M, Kurth T, Maassen Van Den Brink A,Rohmann JL. Giving researchers a headache-sex and gender differencesin migraine. Front Neurol. 2020;11:549038.
19. Katsuki M, Kashiwagi K, Kawamura S, Koh A. The efficacy of Japaneseherbal kampo medicine as an acute and prophylactic medication to treatchronic daily headache and medication overuse headache:-Single armretrospective study. Cureus. 2022;14(5):e25419.
20. Lopresti AL, Smith SJ, Drummond PD. Herbal treatments for migraine: asystematic review of randomised-controlled studies. Phytother Res. 2020;34(10):2493-2517.